Bank Pictet & Cie (Asia)’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$211K Hold
46,020
0.01% 99
2024
Q1
$227K Sell
46,020
-23,000
-33% -$111K 0.02% 99
2023
Q4
$325K Hold
69,020
0.08% 87
2023
Q3
$176K Hold
69,020
0.05% 88
2023
Q2
$309K Hold
69,020
0.09% 81
2023
Q1
$343K Hold
69,020
0.12% 81
2022
Q4
$142K Buy
69,020
+4,600
+7% +$10.3K 0.05% 87
2022
Q3
$169K Hold
64,420
0.07% 87
2022
Q2
$233K Hold
64,420
0.08% 87
2022
Q1
$498K Buy
+64,420
New +$724K 0.14% 83

Other funds holding SOPH

Bank Pictet & Cie (Asia)'s SOPH Position: Q2 2024 in Review

Bank Pictet & Cie (Asia) held its SOPHiA GENETICS (SOPH) position steady in Q2 2024 at 46,020 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #99.

Bank Pictet & Cie (Asia) first reported a position in SOPH in Q1 2022 and has held it in 10 quarters since. The position peaked at $498K in Q1 2022. 31 funds tracked by Wall St. Rank hold SOPH as of Q2 2024.

  • Bank Pictet & Cie (Asia) held 46,020 shares of SOPHiA GENETICS worth $211K as of Q2 2024.
  • Bank Pictet & Cie (Asia) left its SOPHiA GENETICS share count unchanged in Q2 2024.
  • SOPHiA GENETICS made up 0.01% of Bank Pictet & Cie (Asia)'s portfolio in Q2 2024, its #99 holding.
  • Bank Pictet & Cie (Asia) first reported a position in SOPHiA GENETICS in Q1 2022 and has held it in 10 quarters since.
  • Bank Pictet & Cie (Asia)'s SOPHiA GENETICS position peaked at $498K in Q1 2022.
  • 31 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2024.

Based on Bank Pictet & Cie (Asia)'s 13F filing for Q2 2024, filed 16 Jul 2024.